Cargando…

Anti-IgLON5 disease: a novel topic beyond neuroimmunology

Anti-IgLON5 disease is a recently defined autoimmune disorder of the nervous system associated with autoantibodies against IgLON5. Given its broad clinical spectrum and extremely complex pathogenesis, as well as difficulties in its early diagnosis and treatment, anti-IgLON5 disease has become the su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi-ZongHeng, Ni, You, Gao, Yi-Ning, Shen, Ding-Ding, He, Lu, Yin, Dou, Meng, Huan-Yu, Zhou, Qin-Ming, Hu, Ji, Chen, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827781/ https://www.ncbi.nlm.nih.gov/pubmed/36254983 http://dx.doi.org/10.4103/1673-5374.355742

Ejemplares similares

Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017)

Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice
por: Ni, You, et al.
Publicado: (2022)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

Molecular Evolution and Functional Divergence of the IgLON Family
por: Kubick, Norwin, et al.
Publicado: (2018)

Bilateral vestibulopathy in anti-IgLON5 disease
por: Helmchen, Christoph, et al.
Publicado: (2021)

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
por: Lim, Jeong Ho, et al.
Publicado: (2021)

Neuropathological criteria of anti-IgLON5-related tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2016)

Ocular Motor Abnormalities in Anti-IgLON5 Disease
por: Macher, Stefan, et al.
Publicado: (2021)

The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases
por: Salluzzo, Marco, et al.
Publicado: (2023)

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies
por: Simabukuro, Mateus M., et al.
Publicado: (2015)

Isolated dysphagia as initial sign of anti-IgLON5 syndrome
por: Schröder, Jens Burchard, et al.
Publicado: (2016)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder
por: El Shazly, Jasmin, et al.
Publicado: (2021)

Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report
por: Li, Yi, et al.
Publicado: (2023)

Promoter-Specific Expression and Genomic Structure of IgLON Family Genes in Mouse
por: Vanaveski, Taavi, et al.
Publicado: (2017)

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)

Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy
por: Brunetti, Valerio, et al.
Publicado: (2019)

Spatiotemporal expression of IgLON family members in the developing mouse nervous system
por: Fearnley, Sydney, et al.
Publicado: (2021)

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
por: Madetko, Natalia, et al.
Publicado: (2022)

Bilateral horizontal gaze palsy due to Anti-IgLON5 disease
por: Bhatti, M Tariq
Publicado: (2022)

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
por: Cluse, Florent, et al.
Publicado: (2023)

Das Anti-IgLON5-Syndrom in der klinischen Neurologie – zwei Fallberichte
por: Niederschweiberer, Johanna, et al.
Publicado: (2022)

Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report
por: Wang, Yuting, et al.
Publicado: (2021)

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease
por: Shambrook, Pauline, et al.
Publicado: (2021)

IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation
por: Lim, Jeong Ho, et al.
Publicado: (2022)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Anti-IgLON5 disease exacerbated by asymptomatic SARS-CoV-2 infection
por: Li, Xiaoyang, et al.
Publicado: (2023)

P014 IgLON5 Disease – A Review of 2 Cases and Sleep Manifestations
por: Banks, J, et al.
Publicado: (2022)

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
por: Grüter, Thomas, et al.
Publicado: (2020)

IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes
por: Montagna, Massimiliano, et al.
Publicado: (2018)

Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
por: Nissen, Mette Scheller, et al.
Publicado: (2019)

Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome
por: Werner, Jana, et al.
Publicado: (2021)

Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities
por: Urso, Daniele, et al.
Publicado: (2022)

Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice
por: Gao, Yining, et al.
Publicado: (2023)

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease
por: Gaig, Carles, et al.
Publicado: (2019)

Autoimmune encephalitis with anti-IgLON5 and anti-GABA(B)-receptor antibodies: A case report
por: Chung, Ha-Yeun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4uv5tbt0tg5o453lsd8t36tk5m